LOXL1 and lung adenocarcinoma: In patients with lung adenocarcinoma, GO terms related to immune activation, including T‐cell proliferation, T‐cell migration, signal transduction and cytokine production, were significantly upregulated in patients with LOXL1‐mutant tumours (Figure 5G).